Table 1.
Total (N = 15) | |
---|---|
Age (years) | |
Median (range) | 58 (40–73) |
Height (cm) | |
Mean SD | 163.0 ± 7.13 |
Weight (kg) | |
Mean SD | 64.0 ± 8.50 |
Body surface area (m2) | |
Mean SD | 1.642 ± 0.132 |
Gender, n (%) | |
Male | 9 (60.0) |
Female | 6 (40.0) |
ECOG performance status, n (%) | |
0 | 4 (26.7) |
1 | 11 (73.3) |
Tumor type, n (%) | |
NSCLC | 3 (20.0) |
Breast | 2 (13.3) |
Colorectal | 3 (20.0) |
Biliary | 2 (13.3) |
Othera | 5 (33.3) |
Previous treatment, n (%) | |
Surgery | 13 (86.7) |
Radiation | 9 (60.0) |
Chemotherapy | 15 (100.0) |
Prior chemotherapy regimens, n (%) | |
Platinum | 9 (60.0) |
Taxane | 7 (46.7) |
Anthracycline | 6 (40.0) |
No. of prior chemotherapy regimens, n (%) | |
1 | 2 (13.3) |
2 | 2 (13.3) |
3 | 2 (13.3) |
4 | 3 (20.0) |
≥5 | 6 (40.0) |
Median (range) | 4.0 (1–7) |
aOther tumor types include cervical, head and neck, liposarcoma, melanoma, and renal